Analysis | Metabolite Name | Measured Value | Units | Gender | Glycemic status | Neuropathy |
---|---|---|---|---|---|---|
Reversed phase POSITIVE ION MODE | ADENOSINE (M+H)+ | 8368 | Peak area normalized | male | Normoglycemic | Neuropathy |
Reversed phase POSITIVE ION MODE | ADENOSINE (M+H)+ | 8745 | Peak area normalized | female | Diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | ADENOSINE (M+H)+ | 9090 | Peak area normalized | male | Diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | ADENOSINE (M+H)+ | 9687 | Peak area normalized | male | Normoglycemic | no neuropathy |
Reversed phase POSITIVE ION MODE | ADENOSINE (M+H)+ | 10034 | Peak area normalized | male | Pre-diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | ADENOSINE (M+H)+ | 10652 | Peak area normalized | male | Normoglycemic | Neuropathy |
Reversed phase POSITIVE ION MODE | ADENOSINE (M+H)+ | 11304 | Peak area normalized | male | Pre-diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | ADENOSINE (M+H)+ | 15120 | Peak area normalized | female | Pre-diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | ADENOSINE (M+H)+ | 15395 | Peak area normalized | female | Diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | ADENOSINE (M+H)+ | 16705 | Peak area normalized | female | Pre-diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | ADENOSINE (M+H)+ | 18154 | Peak area normalized | male | Diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | ADENOSINE (M+H)+ | 18613 | Peak area normalized | male | Diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | ADENOSINE (M+H)+ | 20078 | Peak area normalized | female | Pre-diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | ADENOSINE (M+H)+ | 20460 | Peak area normalized | male | Pre-diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | ADENOSINE (M+H)+ | 21979 | Peak area normalized | female | Pre-diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | ADENOSINE (M+H)+ | 23336 | Peak area normalized | female | Pre-diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | ADENOSINE (M+H)+ | 24366 | Peak area normalized | female | Pre-diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | ADENOSINE (M+H)+ | 28998 | Peak area normalized | female | Diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | ADENOSINE (M+H)+ | 29326 | Peak area normalized | male | Diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | ADENOSINE (M+H)+ | 34765 | Peak area normalized | female | Pre-diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | ADENOSINE (M+H)+ | 45864 | Peak area normalized | female | Pre-diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | ADENOSINE (M+H)+ | 65893 | Peak area normalized | female | Diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | ADENOSINE (M+H)+ | Peak area normalized | male | Diabetic | Neuropathy | |
Reversed phase POSITIVE ION MODE | ADENOSINE (M+H)+ | Peak area normalized | male | Diabetic | no neuropathy | |
Reversed phase POSITIVE ION MODE | ADENOSINE (M+H)+ | Peak area normalized | male | Normoglycemic | no neuropathy | |
Reversed phase POSITIVE ION MODE | ADENOSINE (M+H)+ | Peak area normalized | male | Pre-diabetic | no neuropathy |